Understanding the symptoms, causes, and risk factors of esophageal cancer is important for early detection and prevention.
Researchers at Case Western Reserve University and University Hospitals are testing a new technology that could screen for ...
Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...
A Midtown-based diagnostics company raised capital in a deal to advance its novel approach to screening for the risk factors ...
Huron Daily Tribune on MSN6d
Coping with cancer: The Hallock family's story of strength and adaptationAccording to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
But a team of researchers led by Kishore Guda, associate professor at the Digestive Health Research Institute at the Case Western Reserve School of Medicine, found a special class of ribonucleic acid ...
The FDA has approved Keytruda plus chemotherapy in HER2+ gastric or GEJ adenocarcinoma with PD-L1–positive expression, based on KEYNOTE-811 data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback